These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An open study of the pyrimethamine-clindamycin combination in AIDS patients with brain toxoplasmosis. Leport C; Bastuji-Garin S; Perronne C; Salmon D; Marche C; Briçaire F; Vilde JL J Infect Dis; 1989 Sep; 160(3):557-8. PubMed ID: 2760509 [No Abstract] [Full Text] [Related]
3. Sulfadiazine-associated obstructive nephropathy occurring in a patient with the acquired immunodeficiency syndrome. Carbone LG; Bendixen B; Appel GB Am J Kidney Dis; 1988 Jul; 12(1):72-5. PubMed ID: 3389358 [TBL] [Abstract][Full Text] [Related]
4. Sulfadiazine crystalluria revisited. The treatment of Toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. Simon DI; Brosius FC; Rothstein DM Arch Intern Med; 1990 Nov; 150(11):2379-84. PubMed ID: 2241449 [TBL] [Abstract][Full Text] [Related]
5. [Cerebral toxoplasmosis as a cause of treatable dementia in an aged patient]. de la Fuente Fernández ; Díaz Benito JA; Rodríguez García JC; Piñeiro Gómez-Durán L Med Clin (Barc); 1991 Apr; 96(15):597-8. PubMed ID: 2051822 [No Abstract] [Full Text] [Related]
6. [Cerebral toxoplasmosis in patients with AIDS]. Altés J; Salas A; Ricart C; Villalonga C; Riera M; Casquero P Arch Neurobiol (Madr); 1989; 52 Suppl 1():121-6. PubMed ID: 2637654 [TBL] [Abstract][Full Text] [Related]
8. Sulfadiazine-induced crystalluria in a patient with the acquired immunodeficiency syndrome: a reminder. Sahai J; Heimberger T; Collins K; Kaplowitz L; Polk R Am J Med; 1988 Apr; 84(4):791-2. PubMed ID: 3400670 [No Abstract] [Full Text] [Related]
9. Comparison of two medications in central nervous system toxoplasmosis in patients with AIDS. Antinori A; Ammassari A; Maiuro G; Camilli G; Damiano F; Federico G; Pizzigallo E; Tamburrini E Ital J Neurol Sci; 1992 Sep; 13(6):475-9. PubMed ID: 1428784 [TBL] [Abstract][Full Text] [Related]
10. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Leport C; Raffi F; Matheron S; Katlama C; Regnier B; Saimot AG; Marche C; Vedrenne C; Vilde JL Am J Med; 1988 Jan; 84(1):94-100. PubMed ID: 3337134 [TBL] [Abstract][Full Text] [Related]
11. Low-dose alternate-day pyrimethamine for maintenance therapy in cerebral toxoplasmosis complicating AIDS. Bhatti N; Larson E J Infect; 1990 Jul; 21(1):119-20. PubMed ID: 2384677 [No Abstract] [Full Text] [Related]
12. Long-term follow-up of patients with AIDS on maintenance therapy for toxoplasmosis. Leport C; Tournerie C; Raguin G; Fernandez-Martin J; Niyongabo T; Vildé JL Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):191-3. PubMed ID: 2060528 [TBL] [Abstract][Full Text] [Related]
13. [Cerebral toxoplasmosis in the acquired immunodeficiency syndrome. Study of the clinical, radiological, and pathological findings in 10 cases]. Bonaventura I; Romero F; Ortega A; Navarro C; Juste C; Codina Puiggrós A Med Clin (Barc); 1988 May; 91(1):1-6. PubMed ID: 3172889 [No Abstract] [Full Text] [Related]
15. Sulfadiazine-induced crystalluria in AIDS patients with toxoplasma encephalitis. Molina JM; Belenfant X; Doco-Lecompte T; Idatte JM; Modai J AIDS; 1991 May; 5(5):587-9. PubMed ID: 1863412 [TBL] [Abstract][Full Text] [Related]
16. Clindamycin therapy of cerebral toxoplasmosis in an AIDS patient. Westblom TU; Belshe RB Scand J Infect Dis; 1988; 20(5):561-3. PubMed ID: 3222671 [TBL] [Abstract][Full Text] [Related]
17. Role of clindamycin in the treatment of central nervous system toxoplasmosis. Rolston KV; Hoy J Am J Med; 1987 Sep; 83(3):551-4. PubMed ID: 3661590 [TBL] [Abstract][Full Text] [Related]
18. [Cerebral toxoplasmosis in immunosuppressed patients: diagnosis and treatment]. Leport C; Vildé JL; Katlama C; Regnier B; Mathéron S; Saimot AG Ann Med Interne (Paris); 1987; 138(1):30-3. PubMed ID: 3592453 [TBL] [Abstract][Full Text] [Related]